Nasdaq Stockholm

Xbrane Biopharma AB

ISIN SE0026598583Filings at the FI

At a glance

Most recent filing on October 28, 2025 — a sale by Siavash Bashiri on Oct 27, 2025.

We hold 4 visible filings, going back to October 24, 2025.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 4 shown

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Siavash Bashiri Deputy chief executive officer
95,468 SEKOpen-market sale
TradedOct 24, 2025FiledOct 28, 2025
Siavash Bashiri Deputy chief executive officer
50,755 SEKOpen-market sale
TradedOct 27, 2025FiledOct 28, 2025
Siavash Bashiri Deputy chief executive officer
3,699 SEKOpen-market sale
TradedOct 24, 2025FiledOct 28, 2025
Siavash Bashiri Deputy chief executive officer
21,623 SEKOpen-market sale
TradedOct 24, 2025FiledOct 28, 2025